News
BridgeBio has received a $300 million upfront payment, strengthening the Company’s balance sheet, and supporting the launch ...
Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection: Shanghai Monday, June 30, 2025, 15:00 Hrs [IST] Mabwell, an innovative ...
Quantum BioPharma (NASDAQ: QNTM) , a biopharmaceutical company focused on innovative biotech assets, announced a non-brokered private placement of cl ...
Director Gareth Edwards (Rogue One) lets Jurassic World: Rebirth be about dinosaurs again, something the last trilogy ...
StockStory.org on MSN16h
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q1 Earnings CallANI Pharmaceuticals' first quarter results were marked by substantial top-line growth, but the market responded negatively, ...
Gen Z billionaires are here! With some leading their companies while others pursue college degrees or quiet lives, these are ...
Opinion
7hOpinion
Daily Maverick on MSNAI slop and the battle for truth — why platform dominance threatens quality informationQuality information is even more important now in an age of AI slop where the information ecosystem is awash in misleading images and strange blah words that sound like they mean something but don’t ...
Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results